Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes

World Journal of Surgical Oncology

Qiang Zhao³  Lu Chen¹  Ying Huang²  Ji-Feng Feng³ 

[1]Department of Gynecologic Surgery, Zhejiang Cancer Hospital, Hangzhou, China

[2]Department of Nursing, Zhejiang Cancer Hospital, Hangzhou, China

[3]Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou, Zhejiang Province 310022, China

关键词: TNM classification;    Overall survival;    Lymph node ratio;    Esophageal cancer;   

Others  :  1204414
DOI  :  10.1186/1477-7819-11-162

 received in 2012-12-26, accepted in 2013-07-08,  发布年份 2013

【 摘 要 】

Background

Recent studies have proposed a new prognostic factor (metastatic lymph node ratio, or MLNR) for patients with esophageal cancer (EC). However, to the best of our knowledge, there have been no studies conducted to date regarding MLNR in elderly patients. The aim of this study was to determine the prognostic value of MLNR staging compared with the 2010 American Joint Committee on Cancer (AJCC) N staging in elderly patients with EC.

Methods

From January 2001 to December 2009, a retrospective analysis of 132 consecutive patients older than 70 years of age with esophageal squamous cell carcinoma (ESCC) was conducted. Prognostic factors for disease-specific survival were analyzed. Receiver operating characteristic curves were also plotted to verify the accuracy of MLNR staging and N staging for survival prediction.

Results

The disease-specific survival rates of N0, N1, N2 and N3 patients according to the AJCC Cancer Staging Manual Seventh Edition N staging were 65.5%, 42.9%, 22.2% and 0, respectively (N0 vs N1, P = 0.017; N1 vsN2, = 0.050; N2 vs N3, P < 0.001). The disease-specific survival rates of MLNR0, MLNR1, MLNR2 and MLNR3 patients were 65.5%, 45.0%, 21.1% and 0, respectively (MLNR0 vsMLNR1, P = 0.026; MLNR1 vs MLNR2, P = 0.033; MLNR2 vs MLNR3, P = 0.015). The areas under the curve were 0.731 for the 2010 AJCC N staging and 0.737 for the MLNR staging.

Conclusion

MLNR is an independent predictor of survival in elderly patients with ESCC. MLNR staging predicts survival after EC similarly to the 2010 AJCC N classifications and should be considered an alternative to current N staging.

【 授权许可】

   
2013 Feng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 4.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Zhao P, Dai M, Chen W, Li N: Cancer trends in China. Jpn J Clin Oncol 2010, 40:281-285.
• [2]Corley DA, Buffler PA: Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 2001, 30:1415-1425.
• [3]Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM: Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002, 95:1434-1443.
• [4]Hou X, Wei JC, Xu Y, Luo RZ, Fu JH, Zhang LJ, Lin P, Yang HX: The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China. Ann Surg Oncol 2013, 20:1653-1659.
• [5]Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW: An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007, 245:717-725.
• [6]Rice TW, Rusch VW, Ishwaran H, Blackstone EH: Worldwide esophageal cancer collaboration: cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American joint committee on cancer/international union against cancer staging manuals . Cancer 2010, 116:3763-3773.
• [7]Poon R, Law SY, Chu KM, Branicki GJ, Wong J: Esophagectomy for carcinoma of the esophagus in the elderly. Ann Surg 1998, 227:357-364.
• [8]Ruol A, Portale G, Zaninotto G, Cagol M, Cavallin F, Castoro C, Sileni VC, Alfieri R, Rampado S, Ancona E: Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival. J Thorac Cardiovasc Surg 2007, 133:1186-1192.
• [9]Wilson M, Rosato EL, Chojnacki KA, Chervoneva I, Kairys JC, Cohn HE, Rosato FE Sr, Berger AC: Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res 2008, 146:11-15.
• [10]Bogoevski D, Onken F, Koenig A, Kaifi JT, Schurr P, Sauter G, Izbicki JR, Yekebas EF: Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 2008, 247:633-641.
• [11]Rizk N, Venkatraman E, Park B, Flores R, Bains M, Rusch V: The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American joint committee on cancer staging system. J Thorac Cardiovasc Surg 2006, 132:1374-1381.
• [12]Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP: Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 2008, 112:1239-1246.
• [13]Yang HX, Xu Y, Fu JH, Wang JY, Lin P, Rong TH: An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China. Ann SurgOncol 2010, 17:1901-1911.
• [14]Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR: The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 2008, 248:549-556.
• [15]Fumagalli U, Akiyama H, DeMeester T: Resective surgery for cancer of the thoracic esophagus: results of a consensus conference held at the VIth world congress of the international society for diseases of the esophagus. Dis Esophagus 1996, 9:30-38.
• [16]Hu Y, Hu C, Zhang H, Ping Y, Chen LQ: How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol 2010, 17:784-790.